BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

ED Deng

​​

Session A-11 – Special Session: Digital Health

Date:25 July (Friday)
Time16:20 – 16:35(GMT+8)

ED Deng

CEO
Health2Sync

​​​
Ed Deng is the Co-founder & CEO of Health2Sync, which he co-founded after witnessing many in his family battle diabetes and learning what works in managing diabetes effectively.  Health2Sync is Asia’s largest chronic disease management platform by the number of digitally connected healthcare providers and patients.   Ed is also a Partner of Verge HealthTech Fund, world's first seed stage healthtech fund investing globally.  Ed serves on the Investor Advisory Board of the Digital Therapeutics Alliance.  Ed started his career as an Investment Banker at Lehman Brothers’s Technology Mergers & Acquisitions Group.  Ed obtained a BS in Commerce-Finance from McIntire School of Commerce at The University of Virginia, where he currently serves on the Global Advisory Board.

 

Catalysts driving digital disease management in Asia Pacific - sensors, automated digital programs, and policy.


In Asia Pacific, digital disease management is gaining momentum through pervasive sensors, real‑time monitoring and engagement via automated digital programs, and supportive policy frameworks.  Real world patient data captured via sensors and health systems enable proactive interventions.  Governments’ investments in digital infrastructure,  interoperability policies, regulation, and reimbursement further catalyze scalable, personalized chronic‑care ecosystems.   When digital programs are deployed, outcomes are demonstrated across the Asia Pacific region and scalable technology will further alleviate for the shortage of clinicians needed for management of chronic diseases.

​​​​​​